Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 21 Researches
8.1
USERS' SCORE
Moderately Good
Based on 6 Reviews
7.9
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Vitamin D3 (as Cholecalciferol) (from Lanolin)
125 mcg (5,000 IU)
625%
Top Medical Research Studies
9
We conducted a study to see how vitamin D affects the recurrence of benign paroxysmal positional vertigo (BPPV), a condition that can cause sudden bouts of dizziness. Our research was carefully designed as a randomized controlled trial, involving two groups: one received vitamin D supplements, while the other was given a placebo. We specifically focused on patients with low vitamin D levels, as previous evidence suggested they might benefit the most from supplementation.
Over the course of a year, the group receiving vitamin D supplements, at a dosage of 7000 IU weekly, showed significantly better results compared to the placebo group. At the six-month and one-year mark, the participants who took vitamin D not only had raised their vitamin D levels but also experienced fewer episodes of vertigo. The statistics revealed a marked decrease in recurrence rates for those taking vitamin D supplements, highlighting its potential role in preventing this frustrating condition.
In conclusion, our findings suggest that vitamin D supplementation could be an effective strategy for those prone to repetitive BPPV episodes, particularly if their initial vitamin D levels were on the low side.
Over the course of a year, the group receiving vitamin D supplements, at a dosage of 7000 IU weekly, showed significantly better results compared to the placebo group. At the six-month and one-year mark, the participants who took vitamin D not only had raised their vitamin D levels but also experienced fewer episodes of vertigo. The statistics revealed a marked decrease in recurrence rates for those taking vitamin D supplements, highlighting its potential role in preventing this frustrating condition.
In conclusion, our findings suggest that vitamin D supplementation could be an effective strategy for those prone to repetitive BPPV episodes, particularly if their initial vitamin D levels were on the low side.
Read More
9
We set out to understand how vitamin D affects vertigo, specifically looking at benign paroxysmal positional vertigo (BPPV). This common condition causes episodes of dizziness when changing head positions. Our study involved 100 patients diagnosed with BPPV, where we measured their vitamin D levels and categorized them as deficient, insufficient, or sufficient. Those with low vitamin D received 2000 IU daily for six months.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
Read More
9
We conducted a thorough study to determine if vitamin D treatment could lower the recurrence rates of Benign Paroxysmal Positional Vertigo (BPPV) in older adults. Utilizing a double-blinded, randomized control design, we followed participants over 12 months. Those classified as vitamin D deficient were divided into two groups: one group received vitamin D3 supplementation, while the other was given a placebo. Participants who had adequate vitamin D levels were observed without treatment, allowing a clear comparison.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
Read More
Most Useful Reviews
10
Resolved vertigo issue
Worked wonders. I had very low vitamin D3 and suffered from severe vertigo and mild tinnitus. Within two months, both conditions improved, and by four months, they were gone. What a relief! No more spinning rooms or ringing bells. It's very inexpensive and effective.
Read More
9
Eased vertigo symptoms
This vitamin D supplement worked wonders for my vertigo. I bought it due to my lack of sunlight exposure, and it alleviated my dizziness as well as improved my sleep and mood. I will continue purchasing it!
Read More
0
Worsened vertigo symptoms
I’m not impressed with this brand. After taking the vitamin D3 supplement for three weeks, I experienced dizziness and vertigo. Upon stopping for two days, symptoms improved considerably. I do not recommend this brand.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 21 Researches
8.1
- All Researches
9.5
We explored a rare case of multicanal benign paroxysmal positional vertigo (BPPV) in a 35-year-old premenopausal woman experiencing osteopenia, a condition characterized by low bone mineral density. Initially diagnosed with unilateral posterior canal BPPV from 2012 to 2014, her symptoms expanded to include involvement of the horizontal and anterior canals by 2015.
We observed that despite undergoing canalith repositioning treatments, the woman's symptoms persisted until she self-administered a daily dose of 5000 IU vitamin D. Interestingly, it was in 2016, after introducing this vitamin D treatment, that she experienced complete resolution of her symptoms.
While we cannot definitively establish a causal relationship between the vitamin D supplementation and the resolution of the vertigo—particularly due to the lack of control groups in this case—it does highlight the potential importance of vitamin D in managing such conditions.
We observed that despite undergoing canalith repositioning treatments, the woman's symptoms persisted until she self-administered a daily dose of 5000 IU vitamin D. Interestingly, it was in 2016, after introducing this vitamin D treatment, that she experienced complete resolution of her symptoms.
While we cannot definitively establish a causal relationship between the vitamin D supplementation and the resolution of the vertigo—particularly due to the lack of control groups in this case—it does highlight the potential importance of vitamin D in managing such conditions.
Read More
9.5
We investigated the impact of Vitamin D deficiency on a patient who developed benign paroxysmal positional vertigo (BPPV) after a successful left-sided stapedotomy. The patient, a 56-year-old woman, had undergone the surgery to address her hearing issues related to otosclerosis. While she initially presented without dizziness, she experienced it a week later, especially when turning to her left side.
Upon testing, she displayed classic signs of BPPV. Notably, we discovered that her serum Vitamin D levels were low. To treat her condition, we employed the Epley's maneuver, a common repositioning technique for BPPV, and within a week, her symptoms improved significantly. This case underscores the often overlooked connection between Vitamin D levels and post-surgical vertigo.
Although our study suggests a link between Vitamin D deficiency and dizziness, it stops short of definitely establishing that Vitamin D treatment directly resolves BPPV. Monitoring Vitamin D and calcium levels could be vital for preventing recurrent dizziness after stapes surgery.
Upon testing, she displayed classic signs of BPPV. Notably, we discovered that her serum Vitamin D levels were low. To treat her condition, we employed the Epley's maneuver, a common repositioning technique for BPPV, and within a week, her symptoms improved significantly. This case underscores the often overlooked connection between Vitamin D levels and post-surgical vertigo.
Although our study suggests a link between Vitamin D deficiency and dizziness, it stops short of definitely establishing that Vitamin D treatment directly resolves BPPV. Monitoring Vitamin D and calcium levels could be vital for preventing recurrent dizziness after stapes surgery.
Read More
9.5
We explored how normalizing vitamin D levels could impact recurrent benign paroxysmal positional vertigo (BPPV) attacks. In this study, researchers conducted a case-control design that included patients who previously experienced multiple BPPV episodes and had low vitamin D levels.
Participants were divided into two groups: a treatment group that received weekly Vitamin D3 supplements, and a control group that did not. Both groups underwent Epley rehabilitation therapy over four weeks. After two months, the treatment group showed a significant increase in vitamin D levels while the control group did not see any change.
Remarkably, during the six-month follow-up, the treatment group experienced a dramatic reduction in BPPV attacks—about 15% had recurrences, compared to a staggering 96% in the control group. This suggests that there is a strong link between adequate vitamin D levels and a reduced risk of recurrent vertigo episodes.
This study highlights a potential breakthrough for those struggling with BPPV, indicating that maintaining healthy vitamin D levels may be a key component in preventing future vertigo episodes.
Participants were divided into two groups: a treatment group that received weekly Vitamin D3 supplements, and a control group that did not. Both groups underwent Epley rehabilitation therapy over four weeks. After two months, the treatment group showed a significant increase in vitamin D levels while the control group did not see any change.
Remarkably, during the six-month follow-up, the treatment group experienced a dramatic reduction in BPPV attacks—about 15% had recurrences, compared to a staggering 96% in the control group. This suggests that there is a strong link between adequate vitamin D levels and a reduced risk of recurrent vertigo episodes.
This study highlights a potential breakthrough for those struggling with BPPV, indicating that maintaining healthy vitamin D levels may be a key component in preventing future vertigo episodes.
Read More
9
We set out to understand how vitamin D affects vertigo, specifically looking at benign paroxysmal positional vertigo (BPPV). This common condition causes episodes of dizziness when changing head positions. Our study involved 100 patients diagnosed with BPPV, where we measured their vitamin D levels and categorized them as deficient, insufficient, or sufficient. Those with low vitamin D received 2000 IU daily for six months.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
Read More
9
We conducted a thorough study to determine if vitamin D treatment could lower the recurrence rates of Benign Paroxysmal Positional Vertigo (BPPV) in older adults. Utilizing a double-blinded, randomized control design, we followed participants over 12 months. Those classified as vitamin D deficient were divided into two groups: one group received vitamin D3 supplementation, while the other was given a placebo. Participants who had adequate vitamin D levels were observed without treatment, allowing a clear comparison.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 6 Reviews
7.9
- All Reviews
- Positive Reviews
- Negative Reviews
10
Resolved vertigo issue
Worked wonders. I had very low vitamin D3 and suffered from severe vertigo and mild tinnitus. Within two months, both conditions improved, and by four months, they were gone. What a relief! No more spinning rooms or ringing bells. It's very inexpensive and effective.
Read More
9
Eased vertigo symptoms
This vitamin D supplement worked wonders for my vertigo. I bought it due to my lack of sunlight exposure, and it alleviated my dizziness as well as improved my sleep and mood. I will continue purchasing it!
Read More
0
Worsened vertigo symptoms
I’m not impressed with this brand. After taking the vitamin D3 supplement for three weeks, I experienced dizziness and vertigo. Upon stopping for two days, symptoms improved considerably. I do not recommend this brand.
Read More
7.5
Prevented vertigo recurrence
A neurologist suggested I take these capsules after experiencing vertigo. Thankfully, that condition hasn't returned since I started taking them.
Read More
7.5
Reduced vertigo attacks
I have a vitamin D3 deficiency and knee joint issues. This dosage has helped significantly with both. I take it every other day and it also helps lessen the frequency of my vertigo attacks. I’m pleased with the results.
Read More
Frequently Asked Questions
10
Resolved vertigo issue
Worked wonders. I had very low vitamin D3 and suffered from severe vertigo and mild tinnitus. Within two months, both conditions improved, and by four months, they were gone. What a relief! No more spinning rooms or ringing bells. It's very inexpensive and effective.
7.5
Cleared vertigo completely
In six months, I've noticed significant improvement. My vertigo has cleared up, and although my knee joints are still crunchy, I feel back to normal and no longer require daytime sleep.
0
Worsened vertigo symptoms
I’m not impressed with this brand. After taking the vitamin D3 supplement for three weeks, I experienced dizziness and vertigo. Upon stopping for two days, symptoms improved considerably. I do not recommend this brand.
9
Eased vertigo symptoms
This vitamin D supplement worked wonders for my vertigo. I bought it due to my lack of sunlight exposure, and it alleviated my dizziness as well as improved my sleep and mood. I will continue purchasing it!
7.5
Prevented vertigo recurrence
A neurologist suggested I take these capsules after experiencing vertigo. Thankfully, that condition hasn't returned since I started taking them.
7.5
Reduced vertigo attacks
I have a vitamin D3 deficiency and knee joint issues. This dosage has helped significantly with both. I take it every other day and it also helps lessen the frequency of my vertigo attacks. I’m pleased with the results.
9
We conducted a thorough study to determine if vitamin D treatment could lower the recurrence rates of Benign Paroxysmal Positional Vertigo (BPPV) in older adults. Utilizing a double-blinded, randomized control design, we followed participants over 12 months. Those classified as vitamin D deficient were divided into two groups: one group received vitamin D3 supplementation, while the other was given a placebo. Participants who had adequate vitamin D levels were observed without treatment, allowing a clear comparison.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
Our findings were promising, revealing an impressive 87% reduction in the recurrence of BPPV for those in the vitamin D group compared to the placebo. Additionally, they experienced significantly longer intervals before their first recurrence of vertigo. Interestingly, no notable differences were observed between the vitamin D group and those who were already vitamin D replete in terms of recurrence rates or related dizziness issues.
This study opens the door for further investigation into the potential of making vitamin D a standard treatment for BPPV. Given that fewer episodes of vertigo may reduce the risk of falls in older adults, this research holds valuable implications for improving seniors' overall postural stability and quality of life.
9
We set out to understand how vitamin D affects vertigo, specifically looking at benign paroxysmal positional vertigo (BPPV). This common condition causes episodes of dizziness when changing head positions. Our study involved 100 patients diagnosed with BPPV, where we measured their vitamin D levels and categorized them as deficient, insufficient, or sufficient. Those with low vitamin D received 2000 IU daily for six months.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
Over one year, we monitored these participants monthly for the incidence, severity, and recurrence of vertigo episodes. Our findings were significant. We observed that 71% of patients with vitamin D deficiency experienced BPPV, compared to just 20% in those with sufficient levels. Moreover, the average severity of symptoms was much higher in those deficient in vitamin D.
Notably, the patients who received vitamin D supplementation saw improvements in both the frequency and severity of their BPPV episodes over time. These results reveal a promising relationship between vitamin D levels and vertigo severity, suggesting that increasing vitamin D could play a vital role in managing BPPV. However, we believe further studies are necessary to explore the underlying mechanisms and the broader implications of our findings on vestibular health.
We explored the effects of vitamin D supplementation combined with diet and a specific treatment called Canalith Repositioning Procedure (CRP) on older patients suffering from Benign Paroxysmal Positional Vertigo (BPPV). This study was designed as a double-blind, placebo-controlled trial, which adds a layer of credibility to our findings by minimizing bias.
Our primary goal was to understand whether vitamin D could lessen the occurrence of BPPV while also improving physical function and reducing the fear of falling among participants. We observed notable improvements among those receiving vitamin D alongside standard care. Notably, participants who followed this regimen performed better on a test measuring their ability to stand up from a chair quickly—an indicator of physical function.
We noted that vitamin D treatment was connected to fewer recurrences of BPPV. Those individuals who did not experience a fall during the study expressed a reduced fear of falling, highlighting a potential mental health benefit as well. However, since this study combined vitamin D with diet and CRP, it leaves us wondering exactly how much vitamin D alone contributed to these positive results.
In conclusion, our findings suggest that incorporating vitamin D supplementation could be beneficial in managing BPPV and enhancing physical function in older adults, though more research is needed to isolate its effects.
Our primary goal was to understand whether vitamin D could lessen the occurrence of BPPV while also improving physical function and reducing the fear of falling among participants. We observed notable improvements among those receiving vitamin D alongside standard care. Notably, participants who followed this regimen performed better on a test measuring their ability to stand up from a chair quickly—an indicator of physical function.
We noted that vitamin D treatment was connected to fewer recurrences of BPPV. Those individuals who did not experience a fall during the study expressed a reduced fear of falling, highlighting a potential mental health benefit as well. However, since this study combined vitamin D with diet and CRP, it leaves us wondering exactly how much vitamin D alone contributed to these positive results.
In conclusion, our findings suggest that incorporating vitamin D supplementation could be beneficial in managing BPPV and enhancing physical function in older adults, though more research is needed to isolate its effects.
9
We explored how vitamin D3 supplementation may influence the intensity of benign paroxysmal positional vertigo (BPPV). This clinical trial specifically aimed to determine whether adding vitamin D3 to rehabilitation efforts—using Epley's maneuver—could enhance patient outcomes.
Our study involved patients diagnosed with BPPV through a thorough history and clinical examination. We evaluated the intensity of their vertigo symptoms using a simple visual analog scale, ranging from 0 to 10. We assessed vitamin D levels in participants, categorizing those with levels below 20 ng/ml as deficient. All of the patients received rehabilitation therapy once a week for a month.
We divided vitamin D deficient patients into two groups: those who received a weekly dose of vitamin D3 (50,000 IU) and those who did not. After two months, both groups showed a significant reduction in the intensity of their vertigo compared to a control group with sufficient vitamin D levels.
However, we observed that the improvement in the non-treated group eventually regressed back to baseline levels, while the group that received vitamin D3 maintained their improvement. This leads us to conclude that correcting vitamin D deficiency not only alleviates BPPV symptoms but also enhances the lasting effects of rehabilitation therapy.
Our study involved patients diagnosed with BPPV through a thorough history and clinical examination. We evaluated the intensity of their vertigo symptoms using a simple visual analog scale, ranging from 0 to 10. We assessed vitamin D levels in participants, categorizing those with levels below 20 ng/ml as deficient. All of the patients received rehabilitation therapy once a week for a month.
We divided vitamin D deficient patients into two groups: those who received a weekly dose of vitamin D3 (50,000 IU) and those who did not. After two months, both groups showed a significant reduction in the intensity of their vertigo compared to a control group with sufficient vitamin D levels.
However, we observed that the improvement in the non-treated group eventually regressed back to baseline levels, while the group that received vitamin D3 maintained their improvement. This leads us to conclude that correcting vitamin D deficiency not only alleviates BPPV symptoms but also enhances the lasting effects of rehabilitation therapy.
9
We conducted a study to see how vitamin D affects the recurrence of benign paroxysmal positional vertigo (BPPV), a condition that can cause sudden bouts of dizziness. Our research was carefully designed as a randomized controlled trial, involving two groups: one received vitamin D supplements, while the other was given a placebo. We specifically focused on patients with low vitamin D levels, as previous evidence suggested they might benefit the most from supplementation.
Over the course of a year, the group receiving vitamin D supplements, at a dosage of 7000 IU weekly, showed significantly better results compared to the placebo group. At the six-month and one-year mark, the participants who took vitamin D not only had raised their vitamin D levels but also experienced fewer episodes of vertigo. The statistics revealed a marked decrease in recurrence rates for those taking vitamin D supplements, highlighting its potential role in preventing this frustrating condition.
In conclusion, our findings suggest that vitamin D supplementation could be an effective strategy for those prone to repetitive BPPV episodes, particularly if their initial vitamin D levels were on the low side.
Over the course of a year, the group receiving vitamin D supplements, at a dosage of 7000 IU weekly, showed significantly better results compared to the placebo group. At the six-month and one-year mark, the participants who took vitamin D not only had raised their vitamin D levels but also experienced fewer episodes of vertigo. The statistics revealed a marked decrease in recurrence rates for those taking vitamin D supplements, highlighting its potential role in preventing this frustrating condition.
In conclusion, our findings suggest that vitamin D supplementation could be an effective strategy for those prone to repetitive BPPV episodes, particularly if their initial vitamin D levels were on the low side.
References
- Huang X, Chua KW, Moh SPS, Yuen HW, Low DYM, et al. Falls and physical function in older patients with Benign Paroxysmal Positional Vertigo (BPPV): findings from a placebo controlled, double blinded randomized control trial (RCT) investigating efficacy of vitamin D treatment in lowering the recurrence rate of BPPV. Aging Clin Exp Res. 2025;37:43. doi:10.1007/s40520-025-02938-4
- Kumar S, Dutta A, Biradar K, Gupta M. Evaluating the Vitamin D Deficiency-BPPV Link: Correlation or Causation?. Indian J Otolaryngol Head Neck Surg. 2024;76:5263. doi:10.1007/s12070-024-04961-9
- Aygun D, Dumur S, Elgormus MN, Alpaslan MS, Uzun H. Serum Otoconin-90 and Otolin-1 Concentrations in Benign Paroxysmal Positional Vertigo. Biomolecules. 2024;14. doi:10.3390/biom14101279
- Lin T, Wu C, Zhang L, Ding L. Association of vitamin-D deficiency with vestibular function in patients with idiopathic benign paroxysmal positional vertigo. J Laryngol Otol. 2025;139:40. doi:10.1017/S0022215124001282
- Chua KW, Huang X, Koh XH, Soh JFJY, Barrera VC, et al. Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults. Otolaryngol Head Neck Surg. 2025;172:127. doi:10.1002/ohn.954
- Bener A, Erdoğan A, Üstündağ ÜV. The Impact of Serums Calcium 25-Hydroxy Vitamin D, Ferritin, Uric Acid, and Sleeping Disorders on Benign Paroxysmal Positional Vertigo Patients. Audiol Res. 2024;14:640. doi:10.3390/audiolres14040054
- Chu C, Chan YM, Tang J. Clinical Outcomes in Patients With Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency: A Singaporean Perspective. Cureus. 2024;16:e60325. doi:10.7759/cureus.60325
- Abedi MS, Flink TS, Roca CP. A Rare Presentation of Multicanal Benign Paroxysmal Positional Vertigo in a Premenopausal Woman With Osteopenia: A Case Report. Cureus. 2024;16:e55421. doi:10.7759/cureus.55421
- Rhim G, Kim MJ. Vitamin D Supplementation and Recurrence of Benign Paroxysmal Positional Vertigo. Nutrients. 2024;16. doi:10.3390/nu16050689
- Kong TH, Jung SY, Seo YJ, Shim DB. Vitamin D supplementation in preventing the recurrence of benign paroxysmal positional vertigo. Laryngoscope Investig Otolaryngol. 2024;9:e1225. doi:10.1002/lio2.1225
- Saeed Al-Rawi TS, Al-Ani RM. Vitamin D Deficiency and the Risk of Recurrent Benign Paroxysmal Positional Vertigo. Cureus. 2024;16:e52433. doi:10.7759/cureus.52433
- Ren YY, Wang YJ, Li JL, Liu M, Xia F. Low vitamin D and uric acid status in patients with benign paroxysmal positional vertigo. Sci Prog. 2023;106:368504231205397. doi:10.1177/00368504231205397
- Chauhan I, Sidhu J, Lal B, Dhadwal M, Azad R. Role of Serum Markers in Benign Paroxysmal Positional Vertigo: Are They Useful?. Indian J Otolaryngol Head Neck Surg. 2023;75:1731. doi:10.1007/s12070-023-03727-z
- Zubčić Ž, Včeva A, Mendeš T, Maleš J, Mihalj H, et al. SUCCESSFUL REPOSITIONING PROCEDURE FOR BENIGN PAROXYSMAL POSITIONAL VERTIGO AFTER STAPEDOTOMY. Acta Clin Croat. 2022;61:547. doi:10.20471/acc.2022.61.03.22
- Sharma K, Ojha T, Dabaria R, Chhabra B, Trivedi BB, et al. Relation Between Posterior Canal Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency. Indian J Otolaryngol Head Neck Surg. 2022;74:4405. doi:10.1007/s12070-021-03070-1
- Shin HI, Park Y, Lee HJ, Jeon EJ. Correlation between serum vitamin D level and benign paroxysmal positional vertigo recurrence. Auris Nasus Larynx. 2023;50:700. doi:10.1016/j.anl.2022.12.017
- Libonati GA, Leone A, Martellucci S, Gallo A, Albera R, et al. Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants. Audiol Res. 2022;12:445. doi:10.3390/audiolres12040045
- Gu X, Dong F, Gu J. Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors. Exp Ther Med. 2018;15:2321. doi:10.3892/etm.2018.5699
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Bakhshi E. The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study. Caspian J Intern Med. 2016;7:173.
- Sheikhzadeh M, Lotfi Y, Mousavi A, Heidari B, Monadi M, et al. Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study. Caspian J Intern Med. 2016;7:93.
- Talaat HS, Kabel AM, Khaliel LH, Abuhadied G, El-Naga HA, et al. Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency. Auris Nasus Larynx. 2016;43:237. doi:10.1016/j.anl.2015.08.009
